BerlinTomek on MSN6d
BMW M3 CSL E46 vs VW Bora VR6 Drag Race Viertelmeile Beschleunigungsrennen Acceleration SoundWatch the BMW M3 CSL E46 take on the VW Bora VR6 in an intense 1/4 mile drag race! Experience the acceleration, engine roar, ...
BMW 750i xDrive features a stunning BMW Individual Voodoo Blue over Ivory White and black Nappa leather configuration ...
Available on the current generation of the BMW M2, M3 and M4, BMW’s M Performance Parts offers a set of lightweight forged ...
CSL Limited (ASX:CSL) shareholders are probably feeling a little disappointed, since its shares fell 4.8% to AU$257 in the week after its latest half-year results. Revenues of US$8.5b were in line ...
MEHUL PATEL, the VP of $CSL, sold 150 shares of the company on 02-08-2025 for an estimated $52,579. We received data on the trade from a recent SEC filing. This was a ...
CSL Behring is anticipated to sustain strong Ig demand and maintain momentum with HEMGENIX uptake and the global launch of ANDEMBRY. CSL Seqirus revenue is projected to benefit from the supply of ...
3d
AutoGuide on MSNBMW’s Centerlock Wheels Now Available For An Absurd PriceBMW’s M Performance Parts Catalog has always given owners a way to improve their M cars, whether for aesthetics, performance, ...
CSL (CSLLY) and Arcturus Therapeutics (ARCT) announced that the European Commission has granted marketing authorization for Kostaive, a self-amplifying mRNA COVID-19 vaccine, for individuals 18 ...
(RTTNews) - CSL Limited (CSL.AX) Thursday, announced that the European Commission has approved ANDEMBRY, a once-monthly treatment for hereditary angioedema or HAE in patients aged 12 and older.
SAN DIEGO, February 14, 2025--(BUSINESS WIRE)--Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today announced that the European ...
CSL Ltd (ASX: CSL) and ResMed Inc (ASX: RMD) shares are popular blue chip options for investors. But are they in the buy zone right now? Let's take a look at what one leading broker is saying ...
CSL Limited (ASX:CSL) shareholders are probably feeling a little disappointed, since its shares fell 4.8% to AU$257 in the week after its latest half-year results. Revenues of US$8.5b were in line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results